KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Evolent Health (EVH) Equity Average (2016 - 2025)

Evolent Health has reported Equity Average over the past 11 years, most recently at $628.7 million for Q4 2025.

  • Quarterly results put Equity Average at $628.7 million for Q4 2025, down 38.36% from a year ago — trailing twelve months through Dec 2025 was $628.7 million (down 38.36% YoY), and the annual figure for FY2025 was $708.2 million, down 31.54%.
  • Equity Average for Q4 2025 was $628.7 million at Evolent Health, down from $869.1 million in the prior quarter.
  • Over the last five years, Equity Average for EVH hit a ceiling of $1.1 billion in Q2 2023 and a floor of $610.8 million in Q3 2021.
  • Median Equity Average over the past 5 years was $919.5 million (2021), compared with a mean of $874.4 million.
  • Biggest five-year swings in Equity Average: skyrocketed 80.92% in 2023 and later tumbled 38.36% in 2025.
  • Evolent Health's Equity Average stood at $650.6 million in 2021, then skyrocketed by 31.85% to $857.8 million in 2022, then rose by 26.13% to $1.1 billion in 2023, then fell by 5.72% to $1.0 billion in 2024, then tumbled by 38.36% to $628.7 million in 2025.
  • The last three reported values for Equity Average were $628.7 million (Q4 2025), $869.1 million (Q3 2025), and $915.8 million (Q2 2025) per Business Quant data.